Kristal Robert Eugene 4
4 · BioRestorative Therapies, Inc. · Filed Nov 4, 2022
Insider Transaction Report
Form 4
Kristal Robert Eugene
Chief Financial Officer
Transactions
- Award
Stock Option
2022-11-03+10,490→ 10,490 totalExercise: $5.08Exp: 2031-11-04→ Common Stock (10,490 underlying) - Disposition to Issuer
Stock Option
2022-11-03−10,490→ 0 totalExercise: $13.50Exp: 2031-11-04→ Common Stock (10,490 underlying)
Holdings
- 7,994
Common Stock
Footnotes (2)
- [F1]The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.
- [F2]The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option with a reduced exercise price.